Report error Found 125 Enz. Inhib. hit(s) with all data for entry = 50023679
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <4nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <4nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <4nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <4nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <4nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <4nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of PRMT5 in MTAP-null human HAP1 cells assessed as reduction in SDMA level incubated for 24 hrs by in-cell western assayMore data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 10nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Inhibition of apo-PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate by fluorescence anisotropy peptide displacement as...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Inhibition of apo-PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate by fluorescence anisotropy peptide displacement as...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <30nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <30nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 30nMAssay Description:Inhibition of apo-PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate by fluorescence anisotropy peptide displacement as...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 30nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <30nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <30nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Inhibition of PRMT5 in MTAP-null human HAP1 cells assessed as reduction in SDMA level incubated for 24 hrs by in-cell western assayMore data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: <30nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Inhibition of PRMT5 in MTAP-null human HAP1 cells assessed as reduction in SDMA level incubated for 24 hrs by in-cell western assayMore data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 40nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 40nMAssay Description:Inhibition of apo-PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate by fluorescence anisotropy peptide displacement as...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 40nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 40nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 50nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 50nMAssay Description:Inhibition of apo-PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate by fluorescence anisotropy peptide displacement as...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:Inhibition of PRMT5 in MTAP-null human HAP1 cells assessed as reduction in SDMA level incubated for 24 hrs by in-cell western assayMore data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 70nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 70nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 80nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 80nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of PRMT5 in MTAP-null human HAP1 cells assessed as reduction in SDMA level incubated for 24 hrs by in-cell western assayMore data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 130nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 150nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 200nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 300nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 300nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 300nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of PRMT5 in MTAP-null human HAP1 cells assessed as reduction in SDMA level incubated for 24 hrs by in-cell western assayMore data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 500nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 500nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 600nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 600nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 700nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 700nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 730nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 800nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.20E+3nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.30E+3nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of SAM by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.30E+3nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair
TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Tango Therapeutics
Curated by ChEMBL
Tango Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.40E+3nMAssay Description:Inhibition of PRMT5/MEP50 (unknown origin) using TAMRA-labeled histone H4 peptide as substrate in presence of MTA by fluorescence anisotropy peptide ...More data for this Ligand-Target Pair






3D Structure (crystal)





















